Willi McFarland
Overview
Explore the profile of Willi McFarland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
367
Citations
6111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Suprasert B, Tate M, McFarland W, Wilson E
Int J Drug Policy
. 2024 Oct;
133:104602.
PMID: 39368230
Background: Drug overdose deaths increased by 50 % between 2017 and 2021 in San Francisco. Little is known about non-fatal overdose, which heralds future risk for morbidity and overdose death....
12.
Ngo H, Pham T, Hoang H, Bui D, Phan H, Nguyen Q, et al.
J Acquir Immune Defic Syndr
. 2024 Sep;
98(1):29-36.
PMID: 39322986
Background: HIV drug resistance can reduce the effectiveness of antiretroviral drugs in preventing morbidity and mortality, limit options for treatment, and prevention. Our study aimed to assess HIV-1 subtypes and...
13.
Chiu I, Cano D, Leathers M, Turner C, Trujillo D, Sicro S, et al.
PLoS One
. 2024 Sep;
19(9):e0307990.
PMID: 39312538
Background: Transgender women (hereafter "trans women") face social marginalization, stigma, and discrimination and experience a high burden of HIV. More recently, trans women have been identified as having a high...
14.
Jalil C, Jalil E, Hoagland B, Cardoso S, Scarparo R, Coutinho C, et al.
Lancet Reg Health Am
. 2024 Jul;
36:100798.
PMID: 38978784
Background: Young gay, bisexual, and other men who have sex with men (YMSM) in Latin America experience disproportionately high rates of HIV. While new case numbers have stabilised in other...
15.
Wilson E, Suprasert B, Trujillo D, Sicro S, Hernandez C, Turner C, et al.
Res Sq
. 2024 Jul;
PMID: 38947081
Introduction: Little is known about differences in HIV risk for trans women by partner gender, particularly with respect to social determinants and partner-level circumstances that affect behavior. We examined differences...
16.
Fraser H, Stone J, Facente S, Artenie A, Patel S, Wilson E, et al.
Int J Drug Policy
. 2024 Jun;
131:104452.
PMID: 38910096
Background: Young adult (18-30 years) people who inject drugs (PWID) face high hepatitis C virus (HCV) prevalence. In San Francisco, where >60% of PWID lack stable housing, barriers hinder HCV...
17.
Wang P, Wei C, McFarland W, Raymond H
J Urban Health
. 2024 May;
101(4):856-866.
PMID: 38787451
Due to stigma or legal issues, populations with higher HIV risk are often hard to reach, which impedes accurate population estimation of HIV burden. To better sample hard-to-reach populations (HTRPs)...
18.
Brookins T, Reagan D, Tate M, Suprasert B, Taylor K, Ruiz R, et al.
AIDS Behav
. 2024 Apr;
28(7):2410-2413.
PMID: 38642211
HIV disproportionately affects Black/African Americans (AA), while PrEP is under-utilized by Black/AA, women, and people who inject drugs (PWID). In San Francisco, California's National HIV Behavioral Surveillance among PWID in...
19.
Suprasert B, Tate M, Reagan D, Ruiz R, Gao K, McNaughton K, et al.
AIDS Behav
. 2024 Mar;
28(6):2089-2100.
PMID: 38526638
Clinical trials provide evidence that pre-exposure prophylaxis (PrEP) prevents HIV acquisition including through sharing of injection equipment among people who inject drugs (PWID). However, uptake among many populations at risk...
20.
Miyashiro R, McFarland W
Am J Forensic Med Pathol
. 2023 Dec;
45(1):40-44.
PMID: 38064360
The Health Officer of the City and County of San Francisco, California, issued the order that all decedents were required to have a documented COVID-19 test effective from June 2020...